USD $26.78
Renvela is a medication used to control phosphorus levels in the blood of patients with chronic kidney disease who are on dialysis. It works by preventing the absorption of phosphate from the diet.
Renvela contains sevelamer carbonate, which binds to dietary phosphate in the digestive tract. This action prevents phosphate from being absorbed into the bloodstream, helping to maintain balanced phosphorus levels.
Renvela is intended for patients with chronic kidney disease on dialysis who need to manage high phosphorus levels. It is important to use this medication under the guidance of a healthcare professional.
Renvela is typically taken orally with meals. The dosage and frequency depend on the patient's medical condition and response to treatment, as determined by a healthcare provider.
Common side effects may include nausea, vomiting, and upset stomach. Patients should contact their healthcare provider if they experience severe or persistent side effects.
Yes, Renvela can interact with certain medications, potentially affecting their absorption and efficacy. It is crucial to inform your healthcare provider about all medications and supplements you are taking.
Patients should follow their healthcare provider's dietary recommendations while using Renvela. Regular monitoring of blood phosphorus levels is also necessary to ensure effective treatment.
For additional details, please consult your healthcare provider or refer to the medication guide provided with the prescription. It is important to use Renvela as directed by a medical professional.
Health Guides